Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

Generated: September 18, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020628

  Try a free trial

See Plans and Pricing

« Back to Dashboard

NDA 020628 describes INVIRASE, which is a drug marketed by Hoffmann La Roche and Hoffmann-la Roche and is included in two NDAs. It is available from two suppliers. Additional details are available on the INVIRASE profile page.

The generic ingredient in INVIRASE is saquinavir mesylate. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the saquinavir mesylate profile page.
Summary for 020628
Applicant:Hoffmann La Roche
Ingredient:saquinavir mesylate
Formulation / Manufacturing:see details
Pharmacology for NDA: 020628
Suppliers and Packaging for NDA: 020628
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
INVIRASE saquinavir mesylate CAPSULE;ORAL 020628 NDA Genentech, Inc. 0004-0245 0004-0245-15 270 CAPSULE in 1 BOTTLE, PLASTIC (0004-0245-15)

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 200MG BASE
Approval Date:Dec 6, 1995TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Queensland Health
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.